Arginase 1 Antibody, mAb, Rabbit
| $210.00 | |
| A02476-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $210.00 | |
| A02476-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Specificity | This product is specific to Arginase 1 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Arginase 1 |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of Liver Arginase in (1) Human fetal liver lysate; (2) Human fetal lung lysate. »
| Target Background | Key element of the urea cycle converting L-arginine to urea and L-ornithine, which is further metabolized into metabolites proline and polyamides that drive collagen synthesis and bioenergetic pathways critical for cell proliferation, respectively; the urea cycle takes place primarily in the liver and, to a lesser extent, in the kidneys. |
| Synonyms | ARG1; Type I arginase; Arginase-1; Liver-type arginase; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.